December 25, 2024 10:44 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Former home secy Ajay Kumar Bhalla appointed Manipur Guv amid ethnic violence resurgence | Five soldiers killed, several injured as Army truck falls into Poonch gorge | Allu Arjun quizzed by police in Pushpa 2 stampede case | Wanted Indian drug smuggler killed in the US | Congress leader files complaint against Allu Arjun for 'insulting police' in Pushpa 2: The Rule | Ahead of Jaishankar's US visit, foreign secretary Vikram Misri meets top US diplomats | India refrains from commenting on extradition request for ousted Bengladeshi PM Sheikh Hasina | I don't blame Allu Arjun, ready to withdraw case: Pushpa 2 stampede victim's husband | Indian New Wave Cinema Architect Shyam Benegal dies at age 90 | Cylinder blast at a temple in Karnataka's Hubbali injures nine people
Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

Mar 28, 2024, at 05:26 am

New Delhi: Hyderabad-based pharmaceutical major Dr. Reddy’s Laboratories Limited (DRL) on Wednesday announced an exclusive partnership with Sanofi Healthcare India Private Limited to promote and distribute Sanofi’s vaccine brands across the country.

Dr Reddy's Q2 Result: Consolidated net profit jumps 30 pc

Dr Reddy's Q2 Result: Consolidated net profit jumps 30 pc

Oct 30, 2021, at 07:00 am

Mumbai/IBNS: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) Friday declared a year-on-year (YoY) rise in consolidated net profit at Rs 992 crore, up 30 per cent.

Dr Reddy's Labs launches Trientine Hydrochloride Capsules in US Market

Dr Reddy's Labs launches Trientine Hydrochloride Capsules in US Market

Feb 07, 2020, at 02:39 pm

Mumbai/UNI Pharma Major Dr Reddy's Laboratories on Friday announced the US launch of Trientine Hydrochloride Capsules a therapeutically equivalent generic version of Syprine (trientine hydrochloride) Capsules, approved by the US Food and Drug Administration (USFDA).